Abstract
A 10-year-old boy with high-risk acute lymphoblastic leukemia treated with hematopoietic stem-cell transplantation developed pulmonary aspergillosis while receiving prophylactic voriconazole. A transpleural aspirate culture revealed a pan-azole-resistant Aspergillus fumigatus. Treatment with liposomal amphotericin B resulted in complete recovery. As the frequency of azole resistance in A. fumigatus increases, invasive procedures to isolate fungi for species identification and susceptibility testing becomes even more important.
| Original language | English |
|---|---|
| Pages (from-to) | 268-270 |
| Number of pages | 3 |
| Journal | The Pediatric infectious disease journal |
| Volume | 30 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2011 |
Keywords
- Amphotericin B
- Antifungal Agents
- Aspergillus fumigatus
- Azoles
- Chemoprevention
- Child
- Drug Resistance, Multiple, Fungal
- Hematopoietic Stem Cell Transplantation
- Humans
- Male
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Aspergillosis
- Pyrimidines
- Treatment Outcome
- Triazoles
- Voriconazole